A lay prescription for tailor-made drugs—focus group reflections on pharmacogenomics
- 28 February 2005
- journal article
- Published by Elsevier in Health Policy
- Vol. 71 (2) , 233-241
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Interviewing the Moderator: An Ancillary Method to Focus GroupsQualitative Health Research, 2004
- Attitudinal barriers to delivery of race-targeted pharmacogenomics among informed lay personsGenetics in Medicine, 2003
- Ethical, Legal, and Social Implications of Genomic MedicineNew England Journal of Medicine, 2003
- For Whom the Cell TollsCurrent Anthropology, 2002
- Ethical perspectives on pharmacogenomic profiling in the drug development processNature Reviews Drug Discovery, 2002
- The Economics of Gene Therapy and of PharmacogeneticsValue in Health, 2002
- The Icelandic genome debateTrends in Biotechnology, 2001
- Citizen involvement in future drug R&D: a Danish Delphi studyForesight, 2000
- Assessing the cost-effectiveness of pharmacogenomicsAAPS PharmSci, 2000
- The methodology of Focus Groups: the importance of interaction between research participantsSociology of Health & Illness, 1994